Stock Information
BioCryst Pharmaceuticals Inc (BCRX)
Ticker Symbol: BCRX
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $2,151.87 mil
Piotroski score: 1
PE Ratio: N/A
EPS (TTM): -1.504
Revenue (TTM): $3.55 M
Dividend Yield: N/A%
ROE: -328.82%
Latest News
-
Why Did BioCryst Pharmaceuticals (BCRX) Shares Climb After Its Latest Update?
Thu, Aug 13, 2026 9:10 AM
-
BioCryst Pharmaceuticals (BCRX) Stock Looks Cheap Even After A 53% Gain
Thu, Aug 13, 2026 7:53 AM
-
BioCryst (BCRX) Q2 2026 Earnings Call Transcript
Wed, Aug 12, 2026 5:29 PM
-
Wall Street Analysts See a 98.74% Upside in BioCryst (BCRX): Can the Stock Really Move This High?
Wed, Aug 12, 2026 1:55 PM
-
Implied Volatility Surging for BioCryst Pharmaceuticals Stock Options
Tue, Aug 11, 2026 2:43 PM
-
A Profitable Rare-Disease Prize: Who Might Snap Up BioCryst?
Tue, Aug 11, 2026 1:20 PM
Key Financials
Financial data not available